Toxic megacolon can be a form of severe clinical course of the infection with Clostridium difficile (ICD), life-threatening, requiring a particular course of treatment. Infection with Clostridium difficile in the Galati Infectious Disease Hospital presents rising number of cases, namely 172 cases in 2014, 271 cases in 2015 and 301 cases in 2016 with clinical evolutions with different severity degrees, including toxic megacolon and death. Among 744 patients with ICD in our clinic, since 1st January 2014 to 31 December 2016. The frequency of toxic megacolon (TM) was 0,537%, so: 3 toxic megacolon cases with favorable evolution with treatment with vancomycin and metronidazole and just one case whose evolution was aggravated under this therapy and evolved favorably under treatment with tigecycline. The work presents this last case of ICD occurred in a 69 years old, immunocompetent man with unknown concomitant chronic diseases which undergoes surgery for bilateral inguinal hernia and receives antibiotherapy with cephalosporin IIIrd generation during surgery and after 7 days develops medium degree ICD with score Atlas 3 and receives therapy with oral vancomycin. He presents clinical aggravation during this therapy with the occurrence of colon dilatation, ascites and right pleurisy at ultrasound and therapy associated with metronidazole is decided. Clinical aggravation continues in this combined therapy with defining the clinical, colonoscopy and tomography criteria for TM and is decided surgical monitoring and replacing antibiotherapy with tigecycline. Evolution is favorable with tigecycline without surgical intervention.
1. Cohen, S., Gerding, D., Johnson, S, Kelly, C., Loo, V., McDonald, C., Pepin, J. & Wilcox, M. (2010). Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA), Infection Control & Hospital Epidemiology, Vol. 31, Issue 5, 431-455, DOI: http://dx.doi.org/10.1086/651706.
2. McDonald, L.C., Owings, M. & Jernigan, D.B. (2006). Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003, Emerging Infectious Diseases Journal, Vol. 12, 409-415.
3. Redelings, M.D., Sorvillo, F. & Mascola, L. (2007). Increase in Clostridium difficile-related mortality rates, United States, 1999-2004, Emerging Infectious Diseases Journal, Vol. 13, 1417-1419.
4. Burckhardt, F., Friedrich, A., Beier, D. & Eckmanns, T. (2008). Clostridium difficile surveillance trends, Saxony, Germany, Emerging Infectious Diseases Journal, Vol. 14, pp. 691-692.
5. Gravel, D., Miller, M., Simor, A., Taylor, G., Gardam, M., McGeer, A., Hutchinson, J., Moore, D., Kelly, S., Boyd, D. & Mulvey, M. (2009). Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis. 48(5), 568-576. doi:
6. Loo, V.G., Poirier, L., Miller, M.A., Oughton, M., Libman, M.D., Michaud, S., Bourgault, A.M., Nguyen, T., Frenette, C., Kelly, M., Vibien, A., Brassard, P., Fenn, S., Dewar, K., Hudson, T.J., Horn, R., Rene, P., Monczak, Y. & Dascal, A. (2005). A predominantly clonal multiinstitutional outbreak of Clostridium difficileassociated diarrhea with high morbidity and mortality. N Engl J Med. 353(23), 2442-2449. doi:
7. Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E. & McDonald, L.C. (2005). Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 366(9491), 1079-1084. doi:
8. Obuch-Woszczatynski, P., Dubiel, G., Harmanus, C., Kuijper, E., Duda, U., Wultanska, D., van Belkum, A. & Pituch, H. (2013). Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland. Eur J Clin Microbiol Infect Dis. 32(8), 1027-1030. doi:
9. Rafila, A., Indra, A., Popescu, G.A., Wewalka, G., Allerberger, F., Benea, S., Badicut, I., Aschbacher, R. & Huhulescu, S. (2014). Occurrence of Clostridium difficile infections due to PCR ribotype 027 in Bucharest, Romania. J Infect Dev Ctries. 8(6), 694-698. doi:
10. Benea, S., Popescu, G.A., Badicut, I., Florea, D., Petrache, D., Gavriliu, L. & Rafila, A.. (2012). Clostridium difficile infections hospitalized in Romanian Institute of Infectious Diseases during the first three months of 2012, Poster Presentation, 4th International Clostridium difficile Symposium, September 20th to 22th, Bled, Slovenia.
11. Bartlett, J.G. & Perl, T.M. (2005). The new Clostridium difficile--what does it mean? N Engl J Med. 353(23), 2503-2505. doi:
12. Arumilli, B.R., Koneru, P. & Fayyaz, I. (2010). Toxic megacolon from hypervirulent Clostridium difficile infection (ribotype 027) following elective total knee replacement: an emerging challenge in modern health care. BMJ Case Rep. 2010. doi:
14. Dumitru, I.M., Dumitru, E., Rugina, S. & Tuta, L.A. (2017). Toxic Megacolon - A Three Case Presentation, The Journal of Critical Care Medicine 3(1):39-44, DOI: 10.1515/jccm-2017-0008.
15. Baroiu, L., Vasile, M.C., Baroiu, N. & Drăgănescu, M. (2015), Aspects of Clostridium difficile infection in Second Department of the Infectious Diseases Hospital Galati, Proceedings of -11th Edition of the Scientific Days of the National Institute of Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest, October 14-16, ISSN 2457-8525, 65-66.
16. Marshak, R.H. & Lester, L.J. (1950). Megacolon a complication of ulcerative colitis. Gastroenterology, 16:768-772.
17. Jalan, K.N., Sircus, W., Card, W.I., Bruce, J., Falconer, C.W., Small, W.P., Smith, A.N. & McManus, J.P.A. (1967). Toxic dilatation of the colon - An experience of 55 cases. Gut. 8:633-638.
18. Wodzinski, M.A., Snowden, J.A. & Reilly, J.T. (1994). Toxic megacolon complicating chemotherapy for acute myeloid leukemia. Postgrad Med J., 70(830):921-3.
19. Hayes-Lattin, B.M., Curtin, P.T., Fleming, W.H., Leis, J.F., Stepan, D.E., Schubach, S. & Maziarz, R.T. (2002). Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis. Bone Marrow Transplant. 30(5), 279-285. doi: